Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science 64

Life Science Digital Health EHR BioTech 64

Healthcare IT Today

OCTOBER 11, 2023

Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. which will partner with 20+ health system partners to guide their transition to value-based care and potentially acquire a health system “where we can demonstrate the blueprint of this transformation for the rest of the industry.”

Life Science 71

Life Science EHR BioTech RCM 71

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93